C3orf64 inhibitors denote a specific class of chemical agents designed to interact with the protein encoded by the C3orf64 gene. The acronym C3orf64 stands for "Chromosome 3 Open Reading Frame 64," which indicates that this gene is located on the third chromosome and is recognized as an open reading frame, a sequence of DNA that could potentially be translated into a protein. While the precise functions of many such ORF-encoded proteins are often not fully delineated, the inhibitors targeting C3orf64 would be crafted based on whatever is known about its structure, expression patterns, and any inferred biological roles. Compounds in this class would be uniquely tailored to bind to the C3orf64 protein, aiming to modulate its activity within the cell. The nature of inhibition could vary; some inhibitors might directly block the active site, preventing the protein from performing its function, while others might bind to regulatory regions, affecting the protein's stability or interactions with other cellular components.
To develop inhibitors for C3orf64, researchers would first need to understand the protein's three-dimensional structure and functional context. If the structure of C3orf64 is resolved through methods like X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy, this would provide a framework for identifying potential binding sites for inhibitors. In cases where the structure is not available, analogous structures of related proteins could be used as templates for modeling. Understanding the protein's role in cellular processes would also be crucial, which could involve studying its expression across various tissues or under different physiological conditions, and investigating its participation in cellular pathways through techniques such as gene knockdowns or overexpression studies. These insights would guide the design of molecules that could specifically target and inhibit the protein.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
It may inhibit DNA methyltransferases, potentially leading to demethylation of the EOGT gene promoter and alteration of its expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
It could similarly cause hypomethylation of the EOGT gene, possibly affecting its transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
This histone deacetylase inhibitor could relax chromatin at the EOGT locus, potentially changing its transcriptional activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylases, it may also affect chromatin structure and gene expression, including that of EOGT. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
If EOGT has GC-rich regions in its promoter, mithramycin A could bind and interfere with transcription factor recruitment. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This antibiotic intercalates into DNA, inhibiting RNA polymerase and possibly decreasing EOGT transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an inhibitor of mTOR, it might downregulate protein synthesis broadly, which could include EOGT. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This PI3K inhibitor can disrupt signaling pathways that may regulate EOGT gene expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
By inhibiting MEK, this compound may affect the MAPK pathway and consequently alter the transcription of genes like EOGT. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
It can affect the stability of transcription factors by inhibiting the proteasome, potentially impacting EOGT expression. | ||||||